Form 4: Arteris CEO Sells Shares for Tax & Trading Plan
Statement of Changes in Beneficial Ownership
Arteris, Inc. President and CEO, K. Charles Janac, reported sales of common stock totaling 18,968 shares in early October 2025, primarily for tax obligations and under a pre-arranged trading plan.
Summary
- K. Charles Janac, President and CEO, Director, and 10% Owner of Arteris, Inc. (AIP), reported sales of common stock.
- On October 2, 2025, Janac sold 7,147 shares (2,767, 1,613, and 2,767 shares) at a price of $10.9208 per share to satisfy tax liabilities arising from the release of restricted stock units.
- On October 3, 2025, an additional 11,821 shares were sold at a weighted average price of $11.0705 per share (with prices ranging from $10.80 to $11.29) as part of a 10b5-1 trading plan adopted on March 5, 2025.
- Following these transactions, Janac directly holds 167,514 shares of common stock.
- Janac also indirectly beneficially owns 9,839,071 shares through Bayview Legacy, LLC and 56,252 shares through the Charles and Lydia Janac Trust.
Sentiment
Score: 5
Explanation: The sales by the CEO are for tax obligations and under a pre-arranged 10b5-1 trading plan, which are common and generally not indicative of a negative outlook on the company's future. However, any insider selling can be viewed with slight caution by the market.
Negatives
- Insider selling by a key executive (President and CEO, Director, 10% Owner) could be perceived negatively by investors, potentially signaling a lack of confidence, although the stated reasons (tax liability, 10b5-1 plan) mitigate this perception.
Risks
- Potential negative market perception due to insider selling, which could put downward pressure on the stock price, despite the routine nature of the transactions.
Future Outlook
No forward-looking statements or guidance are provided in this Form 4 filing.
Industry Context
This Form 4 filing primarily details individual insider transactions and does not provide broader industry context or trends.
Stakeholder Impact
- Shareholders: May interpret insider selling as a negative signal, potentially leading to short-term stock price volatility, though the stated reasons (tax, 10b5-1 plan) mitigate this concern.
Key Dates
| Date | Description |
|---|---|
| 2025-03-05 | Date 10b5-1 trading plan was adopted by K. Charles Janac. |
| 2025-10-02 | Date of sale of 7,147 shares to satisfy tax liability from restricted stock unit release. |
| 2025-10-03 | Date of sale of 11,821 shares under a 10b5-1 trading plan. |
| 2025-10-06 | Date the Form 4 was signed by Paul Alpern as Attorney-in-Fact for K. Charles Janac. |
Recommendation
holdThe insider sales by the CEO are primarily for tax obligations related to RSU vesting and through a pre-established 10b5-1 trading plan. These are routine events and do not necessarily signal a lack of confidence in the company's future prospects. Therefore, based solely on this Form 4, a 'hold' recommendation is appropriate as there's no strong new information to warrant a change in investment thesis, but it's also not a strong positive signal.
Keywords
Arteris Inc., AIP, K. Charles Janac, Insider Trading, Form 4, Stock Sale, CEO, 10b5-1 Plan, Restricted Stock Units, Tax Liability
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.